| NDC Code | 73069-108-31 |
|---|
| Package Description | 1 VIAL, MULTI-DOSE in 1 BOX (73069-108-31) > 5 mL in 1 VIAL, MULTI-DOSE |
|---|
| Product NDC | 73069-108 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Viatrexx-derma |
|---|
| Non-Proprietary Name | Anti-interleukin 1, Ankle Articulations, Beta Endorphin, Bfgf, Calcaneal Tendon, Hip Articulation, Knee Articulation, Liver, Transforming Growth Factor-1, Transforming Gf-beta |
|---|
| Dosage Form | INJECTION |
|---|
| Usage | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS |
|---|
| Start Marketing Date | 20190329 |
|---|
| Marketing Category Name | UNAPPROVED DRUG OTHER |
|---|
| Manufacturer | VIATREXX BIO INCORPORATED |
|---|
| Substance Name | BASIC FIBROBLAST GROWTH FACTOR (HUMAN); CALCIUM GLUCONATE; CENTELLA ASIATICA; PORK COLLAGEN; HYALURONIDASE; MECASERMIN; BOS TAURUS PLACENTA; SUS SCROFA PLACENTA |
|---|
| Strength | 200; 30; 30; 200; 30; 200; 30; 30 |
|---|
| Strength Unit | [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL |
|---|
| Pharmacy Classes | Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS],Endoglycosidase [EPC],Glycoside Hydrolases [CS] |
|---|